Stocks
Dyne Therapeutics, Inc.DYN
NASDAQHealthcareBiotechnology$15.23
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing oligonucleotide therapies for serious muscle diseases, including myotonic dystrophy type 1 and Duchenne muscular dystrophy. Its lead candidates, AOC 1001 and AOC 1044, use antibody-oligonucleotide conjugates to target muscle tissue, a delivery approach that has drawn attention from investors tracking the RNA therapeutics space. The company's progress through clinical trials and its cash runway are key metrics for shareholders.
52W Range: $14.00-$27.30
Congressional Interest in Dyne Therapeutics, Inc. (DYN)
No congressional trades have been disclosed for Dyne Therapeutics, Inc. (DYN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading DYN?
No congressional trades found for this stock.